Mexican President Congratulates Researchers on Approval of “Patria” COVID-19 Vaccine

2024-01-29 01:39:27

President Andrés Manuel López Obrador congratulated the Conahcyt and Avimez researchers who developed the “Patria” vaccine once morest the SARS-CoV-2 virus, which was approved for emergency use two days ago.

“The Mexican Patria vaccine once morest COVID-19 has already been approved by specialists. Congratulations to the CONAHCYT and Avimex researchers,” said the President through a message that he spread on his social networks.

Last Friday, “Patria’ received a favorable opinion for its emergency use in the adult population.

Read also: Welfare Pension: Delivery of the Welfare Card for new beneficiaries announced

This was unanimously resolved, in an extraordinary session, by the Committee on New Molecules (CMN) of the Federal Commission for the Protection once morest Sanitary Risks (Cofepris) of Mexico, who agreed that the information presented by the national manufacturer Avi-Mex was sufficient. .

{{#values}}
{{#ap}}

{{/ap}}
{{^ap}}

{{/ap}}
{{/values}}

“The favorable opinion on the AVX/COVID-12 vaccine, with the NDV recombinant platform, developed by Avi-Mex, indicated for the active immunization of people over 18 years of age intramuscularly will allow, if all stages are successfully completed, to obtain authorization for emergency use,” Cofepris said in a statement.


Join our channel

EL UNIVERSAL is now on Whatsapp! From your mobile device, find out the most relevant news of the day, opinion articles, entertainment, trends and more.

rmlgv

1706501046
#AMLO #congratulates #researchers #Conahcyt #Avimez #development #Patria #vaccine

Leave a Replay